Literature DB >> 11733919

Secondary sclerosing cholangitis and portal hypertension after O157 enterocolitis: Extremely rare complications of hemolytic uremic syndrome.

N Urushihara1, N Ariki, T Oyama, Y Chouda, T Yagi, T Inoue, Y Tomiyama, R Nishiuchi, M Oda, N Tanaka.   

Abstract

The authors experienced an extremely rare case of secondary sclerosing cholangitis and portal hypertension developed as late complications of hemolytic uremic syndrome (HUS) owing to Escherichia coli O157:H7 in a 2-year-old boy. HUS after E coli O157 infection is the most frequent cause of acute renal failure in childhood and occasionally is accompanied by extrarenal complications such as encephalopathy, cardiomyopathy, ischemic colitis, and pancreatitis. Rarely, late colonic stenosis may develop secondary to the ischemic damage. Sclerosing cholangitis and subsequent cirrhosis with portal hypertension are very uncommon as late complications of HUS. To our knowledge, such a case has not been previously reported in the literature. J Pediatr Surg 36:1838-1840. Copyright 2001 by W.B. Saunders Company.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733919     DOI: 10.1053/jpsu.2001.28858

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  SERPINB11 variant-related liver injury in STEC-HUS: case reports and literature review.

Authors:  Nazlı Umman; Mey Talip Petmezci; Çiğdem Arikan; Cansu Altuntaş; Biray Ertürk; Hasan Dursun
Journal:  Pediatr Nephrol       Date:  2022-05-12       Impact factor: 3.651

2.  Escherichia coli-associated hemolytic uremic syndrome and severe chronic hepatocellular cholestasis: complication or side effect of eculizumab?

Authors:  Mathilde Mauras; Justine Bacchetta; Anita Duncan; Marie-Pierre Lavocat; Barbara Rohmer; Etienne Javouhey; Sophie Collardeau-Frachon; Anne-Laure Sellier-Leclerc
Journal:  Pediatr Nephrol       Date:  2019-04-08       Impact factor: 3.714

3.  Klatskin-like lesions.

Authors:  M P Senthil Kumar; R Marudanayagam
Journal:  HPB Surg       Date:  2012-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.